Loading company…
MedinCell S.A. in France develops long-acting injectable therapies using its BEPO technology for chronic conditions.
Founded in 2002 and headquartered in Montpellier, France, MedinCell S.A. is a biopharmaceutical company that develops long-acting injectable therapies. Its pipeline includes mdc-TJK, an investigational monthly olanzapine injection for schizophrenia. The company has raised EUR 15.60 mn through 6 deals, including a PIPE round on May 12, 2023 with BNP Paribas Developpement and Mirova. Anh Nguyen founded the company.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in